Crovalimab (Anti-Complement C5)
Crovalimab (Anti-Complement C5) (A2812-GRP)
Products
Description
Crovalimab (Anti-Complement C5) is a humanized recycling monoclonal antibody directed against the complement pathway protein C5, with potential complement pathway inhibitory and immunomodulating activities. MW : 145.28 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2812 |
| Target | Complement System |